Sifflet | $18,000,000 | (Jun 24, 2025)
RevelAi Health | $3,100,000 | (Jun 24, 2025)
Botpress | $25,000,000 | (Jun 24, 2025)
Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
Veda | $18,000,000 | (Jun 24, 2025)
Meridian | $7,000,000 | (Jun 24, 2025)
Spinwheel | $30,000,000 | (Jun 24, 2025)
Stackup | $4,200,000 | (Jun 24, 2025)
VoiceCare AI | $4,500,000 | (Jun 24, 2025)
YieldClub | $2,500,000 | (Jun 24, 2025)
Steuerboard | $841,106,314 | (Jun 24, 2025)
Snowcap Compute Inc. | $23,000,000 | (Jun 24, 2025)
Profound | $20,000,000 | (Jun 24, 2025)